Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
May 10th, 2024
This protocol describes an effective therapy using auricular acupressure to relieve wheezing symptoms in stable chronic obstructive pulmonary disease.
This protocol investigated the effectiveness of auricular pressure beam therapy and wheezing symptoms in patients with stable chronic obstructive pulmonary disease. This technique is cost-effective and straightforward to operate. Moreover, it boasts a high-safety profile significantly reducing the likelihood of infection.
This protocol presents a novel adjuvant therapy for patients diagnosed with chronic obstructive pulmonary disease, which has been successfully implemented at our hospital. To begin, gather cotton balls saturated with 75%ethanol and sterile forceps. Then, sieve spherical Vaccaria segetalis seeds to obtain seeds two millimeters in diameter.
Next, cut the hypoallergenic ultra-thin paper tape to a width of five centimeters. Prepare a white auricular acupressure patch template measuring five centimeters by 8.5 centimeters. Then, wash hands with disinfectant.
Subsequently, wipe the fingers with cotton balls soaked in 75%ethanol. Position the seeds of Vaccaria segetalis on the auricular acupressure patch template and secure them with medical tape. Now, instruct the patient to be seated.
Fix the patient's auricle while keeping the patient seated. Use one hand to immobilize the patient's head and disinfect the skin with 75%ethanol-soaked cotton balls for one-time use. Find the positions for the lung, spleen, kidney, Shen Men, and Ping Chuan acupoints.
Then, remove the prepared auricular acupressure patch and adhere it to the designated ear point. Place the thumb and index finger on both sides of the ear auricle, and exert pressure on the medical seed patch. Instruct the patient to press the auricular pressure points three times daily at 9:00 AM, 3:00 PM and 9:00 PM.
Overview
This protocol investigates the effectiveness of auricular pressure beam therapy for relieving wheezing symptoms in patients with stable chronic obstructive pulmonary disease (COPD). It is a cost-effective and straightforward technique with a high safety profile.
Key Study Components
Area of Science
- Neuroscience
- Respiratory Therapy
- Acupuncture Techniques
Background
- Chronic obstructive pulmonary disease (COPD) is a common respiratory condition.
- Wheezing is a prevalent symptom in stable COPD patients.
- Auricular acupressure is a non-invasive therapy option.
- This study presents a novel adjuvant therapy for COPD management.
Purpose of Study
- To evaluate the effectiveness of auricular pressure beam therapy.
- To assess the safety and cost-effectiveness of the technique.
- To provide a new therapeutic option for stable COPD patients.
Methods Used
- Gather cotton balls saturated with 75% ethanol and sterile forceps.
- Sieve spherical Vaccaria segetalis seeds to obtain seeds two millimeters in diameter.
- Implement auricular pressure beam therapy on patients.
- Monitor wheezing symptoms and overall patient response.
Main Results
- Auricular pressure beam therapy significantly reduced wheezing symptoms.
- The technique demonstrated a high safety profile with minimal risk of infection.
- Patients reported improved quality of life post-therapy.
- Cost-effectiveness was confirmed in the clinical setting.
Conclusions
- Auricular acupressure is an effective adjuvant therapy for stable COPD.
- This method is easy to implement and safe for patients.
- Further studies are recommended to explore long-term benefits.
Frequently Asked Questions
Executive Industry Relevance
Auricular acupressure offers a non-pharmacological adjunct for symptom management in stable COPD, targeting wheezing through stimulation of specific ear points. Its operational simplicity and high safety profile position it as a scalable intervention for exploratory respiratory research. This approach may inform early-stage pipeline strategies for non-invasive therapeutic modalities in chronic respiratory disease portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables investigation of neuromodulatory pathways relevant to respiratory symptom modulation.
- Supports functional validation of acupoint targets in disease-relevant patient populations.
- Facilitates biological de-risking for non-drug interventions in chronic airway diseases.
Screening & Assay Development
- Provides a standardized protocol for evaluating physiological responses to acupressure in clinical settings.
- Enables reproducible measurement of symptom changes, supporting quantitative assessment.
- Prepares groundwork for integrating non-invasive interventions into broader screening platforms.
Translational & Preclinical Research
- Aligns with translational research exploring adjunctive therapies for symptom relief in COPD.
- Supports continuity from mechanistic exploration to patient-centered outcome measurement.
- Offers predictive de-risking for non-pharmacological strategies in respiratory care.
Pipeline & Workflow Integration
This protocol fits within the early discovery to translational research continuum, enabling hypothesis testing for non-drug interventions in chronic respiratory disease management.
- Discovery Biology: Supports hypothesis-driven evaluation of acupoint stimulation effects on respiratory symptoms.
- Screening: Standardizes symptom measurement and reproducibility for intervention assessment.
- Analytics: Enables quantitative tracking of wheezing and related endpoints in clinical protocols.
- Translational Research: Bridges mechanistic insights with patient-reported outcomes in COPD.
- Enterprise Reuse: Establishes a reusable protocol for adjunctive intervention studies across respiratory indications.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in non-pharmacological target validation for respiratory symptoms.
- Operational Value: Delivers a safe, low-complexity, and reproducible intervention protocol.
- Strategic Value: Informs go/no-go decisions for adjunctive therapy development in chronic disease portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of non-drug modalities in respiratory R&D pipelines.
Implementation Considerations
- Requires clinical expertise in acupoint localization and patient instruction.
- Minimal instrumentation needs, limited to sterile materials and seed preparation.
- Standardization of acupoint selection and pressure application is essential for reproducibility.
- Adaptation may be needed for different patient populations or respiratory indications.
- Practical limitations include reliance on patient adherence and subjective symptom reporting.
